FDA approves Merck's drug for rare, deadly lung condition
Publishing timestamp: 2024-03-26 17:13:44
Summary
The FDA approved Merck's drug Winrevair to treat a rare lung condition, a win for both the drugmaker and patients. The drug is the first to target the root cause of the condition and is expected to be a significant growth driver for Merck.
Sentiment: POSITIVE
Tickers: MRK,
Keywords: business news, science, merck & co inc, fda, business, breaking news, health care industry, pharmaceuticals, biotechnology, biotech and pharmaceuticals,